For patients for whom traditional open-heart surgery is not a viable option, a procedure called transcatheter aortic valve replacement (TAVR) is available as a treatment option at Franciscan Health - Indianapolis.
The Transcatheter Valve is designed to replace a patient’s diseased native aortic valve without traditional open-heart surgery and while the heart continues to beat – obviating the need for cardiopulmonary bypass. The therapy provides an important new treatment option for certain inoperable patients. This is the first transcatheter aortic valve replacement therapy approved for use and Franciscan Health is able to perform the procedure on qualified patients.
The transcatheter procedure places a collapsible aortic heart valve into the body. There are multiple ways our cardiovascular specialists gain access for delivery of TAVR devices, including via the femoral artery in the thigh, transapical or through the tip of the heart, directly through the aorta, or through subclavian or axillary sites. It is a significant procedure involving general anesthesia, and placement of the transcatheter valve is associated with specific contraindications as well as serious adverse effects which your cardiovascular specialist will discuss with you. In addition, the longevity of the valve’s function is not yet known, but may last at least five years.
The Franciscan Health Heart Valve Center Indianapolis was the first multidisciplinary center in Indiana dedicated to the evaluation and treatment of heart valve disease. The Heart Valve Center team’s depth of experience working together to treat complex valve disorders makes the new technology a natural addition to the care they offer.